WallStreetZenWallStreetZen

NASDAQ: INDV
Indivior Pharmaceuticals Inc Stock Ownership - Who owns Indivior Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Indivior Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christian HeidbrederChief Scientific Officer2026-07-1018,586$41.14
$764.63kSell
Joseph CiaffoniChief Executive Officer2026-06-22612,549$38.32
$23.47MSell
Christian HeidbrederChief Scientific Officer2026-06-1118,586$38.06
$707.38kSell
Ryan PreblickChief Financial Officer2026-06-0836,000$37.70
$1.36MSell
Juliet ThompsonDirector2026-05-121,117$38.28
$42.76kSell
Ryan PreblickChief Financial Officer2026-03-142,843$31.11
$88.45kSell
Barbara RyanDirector2026-03-138$31.09
$248.68Buy
Barbara RyanDirector2026-03-0931$32.56
$1.01kBuy
Stuart A. KingsleyDirector2026-03-06940$31.87
$29.95kBuy
Jeffrey W. BurrisChief Legal Officer2026-03-0336,032$31.98
$1.15MSell

1 of 2

INDV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INDV insiders and whales buy or sell their stock.

INDV Shareholders

What type of owners hold Indivior Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.21%18,542,220$745.77MInstitution
Vanguard Portfolio Management LLC6.47%7,891,819$317.41MInstitution
Oaktree Capital Management LP5.73%6,984,102$280.90MInstitution
Vanguard Capital Management LLC4.58%5,586,576$224.69MInstitution
State Street Corp4.02%4,903,993$197.24MInstitution
Two Seas Capital LP3.89%4,746,510$190.90MInstitution
Millennium Management LLC3.77%4,595,535$184.83MInstitution
Fuller Thaler Asset Management Inc3.72%4,529,583$182.18MInstitution
Madison Avenue Partners LP3.54%4,315,162$173.56MInstitution
Citadel Advisors LLC2.93%3,574,044$143.75MInstitution

1 of 3

INDV vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INDV98.80%1.20%Net SellingNet Selling
AMRX29.90%70.10%Net SellingNet Selling
LNTH51.87%48.13%Net SellingNet Selling
RGC0.13%88.80%
SUPN45.70%54.30%Net Buying
View Top Pharmaceutical Stocks

Indivior Pharmaceuticals Stock Ownership FAQ

Who owns Indivior Pharmaceuticals?

Indivior Pharmaceuticals (NASDAQ: INDV) is owned by 104.76% institutional shareholders, 1.28% Indivior Pharmaceuticals insiders, and 0.00% retail investors. Blackrock Inc is the largest individual Indivior Pharmaceuticals shareholder, owning 18.54M shares representing 15.21% of the company. Blackrock Inc's Indivior Pharmaceuticals shares are currently valued at $741.87M.

If you're new to stock investing, here's how to buy Indivior Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.